Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Neurobiology and treatment advances for prolonged grief disorder
    Published on 2023-07-21
    3 years ago
  • Herpesviruses and neuropsychiatric disorders: overlooked adversaries or innocent bystanders?
    Published on 2023-07-21
    3 years ago
  • Ventral prefrontal network response to alcohol in young adults with bipolar disorder: a within-subject randomized placebo-controlled alcohol administration study
    Published on 2023-07-20
    3 years ago
  • Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain
    Published on 2023-07-20
    3 years ago
  • A paraventricular thalamus to insular cortex glutamatergic projection gates “emotional” stress-induced binge eating in females
    Published on 2023-07-20
    3 years ago
  • Correction: Divergent modulation of pain and anxiety by GABAergic neurons in the ventrolateral periaqueductal gray and dorsal raphe
    Published on 2023-07-19
    3 years ago
  • The biological embedding of structural inequities: new insight from neuroscience
    Published on 2023-07-18
    3 years ago
« Previous 1 … 120 121 122 123 124 … 143 Next »
Journal of Psychopharmacology
  • A single administration of ‘microbial’ D-alanine to healthy volunteers augments reaction to negative emotions: A comparison with D-serine
    Published on 2020-03-13
    6 years ago
  • Using loss- and gain-of-function approaches to target amygdala-projecting serotonergic neurons in the dorsal raphe nucleus that enhance anxiety-related and conditioned fear behaviors
    Published on 2020-03-10
    6 years ago
  • Increased dopamine availability magnifies nicotine effects on cognitive control: A pilot study
    Published on 2020-03-05
    6 years ago
  • Association between thiopurine exposure and depression in patients with inflammatory bowel disease and rheumatoid arthritis
    Published on 2020-03-04
    6 years ago
  • A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
    Published on 2020-03-04
    6 years ago
  • Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial
    Published on 2020-03-03
    6 years ago
  • Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials
    Published on 2020-03-03
    6 years ago
« Previous 1 … 120 121 122 123 124 … 150 Next »
European Neuropsychopharmacology
  • P.212 Alcohol use impacts reward network structure in bipolar disorder
    Published on 2021-02-26
    5 years ago
  • P.103 Targeting nitric oxide synthase 1 adaptor protein rescues schizophrenia-related alterations in dendritic morphology
    Published on 2021-02-26
    5 years ago
  • P.213 Modulation of n-acylethanolamines restores the cognitive deficits induced by early alcohol exposure
    Published on 2021-02-26
    5 years ago
  • P.104 Redox imbalance in patients with first episode of schizophrenia, it’s association with clinical and cognitive features
    Published on 2021-02-26
    5 years ago
  • P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental study
    Published on 2021-02-26
    5 years ago
  • P.106 Epigenome-wide DNA methylation in externalizing behaviours: a review and meta-analysis
    Published on 2021-02-26
    5 years ago
  • P.224 Eating behaviours in a sample of 141 candidates for bariatric surgery: clinical and psychopathological correlates
    Published on 2021-02-26
    5 years ago
« Previous 1 … 120 121 122 123 124 … 168 Next »

   Pharma Pub